203 related articles for article (PubMed ID: 20674883)
1. Echinacea and its alkylamides: effects on the influenza A-induced secretion of cytokines, chemokines, and PGE₂ from RAW 264.7 macrophage-like cells.
Cech NB; Kandhi V; Davis JM; Hamilton A; Eads D; Laster SM
Int Immunopharmacol; 2010 Oct; 10(10):1268-78. PubMed ID: 20674883
[TBL] [Abstract][Full Text] [Related]
2. Mast cell degranulation and calcium influx are inhibited by an Echinacea purpurea extract and the alkylamide dodeca-2E,4E-dienoic acid isobutylamide.
Gulledge TV; Collette NM; Mackey E; Johnstone SE; Moazami Y; Todd DA; Moeser AJ; Pierce JG; Cech NB; Laster SM
J Ethnopharmacol; 2018 Feb; 212():166-174. PubMed ID: 29042288
[TBL] [Abstract][Full Text] [Related]
3. Purification of alkylamides from Echinacea angustifolia (DC.) Hell. Roots by high-speed countercurrent chromatography.
Lopes-Lutz D; Mudge E; Ippolito R; Brown P; Schieber A
J Agric Food Chem; 2011 Jan; 59(2):491-4. PubMed ID: 21190380
[TBL] [Abstract][Full Text] [Related]
4. Cytochrome P450 inhibitory action of Echinacea preparations differs widely and co-varies with alkylamide content.
Modarai M; Gertsch J; Suter A; Heinrich M; Kortenkamp A
J Pharm Pharmacol; 2007 Apr; 59(4):567-73. PubMed ID: 17430641
[TBL] [Abstract][Full Text] [Related]
5. Light-mediated antifungal activity of Echinacea extracts.
Binns SE; Purgina B; Bergeron C; Smith ML; Ball L; Baum BR; Arnason JT
Planta Med; 2000 Apr; 66(3):241-4. PubMed ID: 10821050
[TBL] [Abstract][Full Text] [Related]
6. Ethanolic Echinacea purpurea Extracts Contain a Mixture of Cytokine-Suppressive and Cytokine-Inducing Compounds, Including Some That Originate from Endophytic Bacteria.
Todd DA; Gulledge TV; Britton ER; Oberhofer M; Leyte-Lugo M; Moody AN; Shymanovich T; Grubbs LF; Juzumaite M; Graf TN; Oberlies NH; Faeth SH; Laster SM; Cech NB
PLoS One; 2015; 10(5):e0124276. PubMed ID: 25933416
[TBL] [Abstract][Full Text] [Related]
7. Alkylamides from echinacea modulate induced immune responses in macrophages.
Matthias A; Banbury L; Stevenson LM; Bone KM; Leach DN; Lehmann RP
Immunol Invest; 2007; 36(2):117-30. PubMed ID: 17365014
[TBL] [Abstract][Full Text] [Related]
8. Absorption of dodeca-2E,4E,8Z,10E/Z-tetraenoic acid isobutylamides after oral application of Echinacea purpurea tincture.
Dietz B; Heilmann J; Bauer R
Planta Med; 2001 Dec; 67(9):863-4. PubMed ID: 11745026
[TBL] [Abstract][Full Text] [Related]
9. High performance liquid chromatography/electrospray ionization mass spectrometry for simultaneous analysis of alkamides and caffeic acid derivatives from Echinacea purpurea extracts.
Cech NB; Eleazer MS; Shoffner LT; Crosswhite MR; Davis AC; Mortenson AM
J Chromatogr A; 2006 Jan; 1103(2):219-28. PubMed ID: 16298376
[TBL] [Abstract][Full Text] [Related]
10. Macrophage activating effects of new alkamides from the roots of Echinacea species.
Chen Y; Fu T; Tao T; Yang J; Chang Y; Wang M; Kim L; Qu L; Cassady J; Scalzo R; Wang X
J Nat Prod; 2005 May; 68(5):773-6. PubMed ID: 15921428
[TBL] [Abstract][Full Text] [Related]
11. Echinacea alkylamides modulate TNF-alpha gene expression via cannabinoid receptor CB2 and multiple signal transduction pathways.
Gertsch J; Schoop R; Kuenzle U; Suter A
FEBS Lett; 2004 Nov; 577(3):563-9. PubMed ID: 15556647
[TBL] [Abstract][Full Text] [Related]
12. Absolute/relative bioavailability and metabolism of dodeca-2E,4E,8Z,10E/Z-tetraenoic acid isobutylamides (tetraenes) after intravenous and oral single doses to rats.
Ardjomand-Woelkart K; Kollroser M; Magnes C; Sinner F; Frye RF; Derendorf H; Bauer R; Butterweck V
Planta Med; 2011 Nov; 77(16):1794-9. PubMed ID: 21604240
[TBL] [Abstract][Full Text] [Related]
13. Metabolomic profiling of liquid Echinacea medicinal products with in vitro inhibitory effects on cytochrome P450 3A4 (CYP3A4).
Modarai M; Yang M; Suter A; Kortenkamp A; Heinrich M
Planta Med; 2010 Mar; 76(4):378-85. PubMed ID: 19790031
[TBL] [Abstract][Full Text] [Related]
14. Echinacea alkylamides inhibit interleukin-2 production by Jurkat T cells.
Sasagawa M; Cech NB; Gray DE; Elmer GW; Wenner CA
Int Immunopharmacol; 2006 Jul; 6(7):1214-21. PubMed ID: 16714226
[TBL] [Abstract][Full Text] [Related]
15. Role for PPARgamma in IL-2 inhibition in T cells by Echinacea-derived undeca-2E-ene-8,10-diynoic acid isobutylamide.
Spelman K; Iiams-Hauser K; Cech NB; Taylor EW; Smirnoff N; Wenner CA
Int Immunopharmacol; 2009 Oct; 9(11):1260-4. PubMed ID: 19712756
[TBL] [Abstract][Full Text] [Related]
16. Simultaneous analysis of caffeic acid derivatives and alkamides in roots and extracts of Echinacea purpurea by high-performance liquid chromatography-photodiode array detection-electrospray mass spectrometry.
Luo XB; Chen B; Yao SZ; Zeng JG
J Chromatogr A; 2003 Jan; 986(1):73-81. PubMed ID: 12585324
[TBL] [Abstract][Full Text] [Related]
17. Chromatographic methods for metabolite profiling of virus- and phytoplasma-infected plants of Echinacea purpurea.
Pellati F; Epifano F; Contaldo N; Orlandini G; Cavicchi L; Genovese S; Bertelli D; Benvenuti S; Curini M; Bertaccini A; Bellardi MG
J Agric Food Chem; 2011 Oct; 59(19):10425-34. PubMed ID: 21830789
[TBL] [Abstract][Full Text] [Related]
18. A sensitive LC-MS/MS method for the quantitative analysis of the Echinacea purpurea constituent undeca-2-ene-8,10-diynoic acid isobutylamide in human plasma.
Goey AK; Sparidans RW; Meijerman I; Rosing H; Schellens JH; Beijnen JH
J Chromatogr B Analyt Technol Biomed Life Sci; 2011 Jan; 879(1):41-8. PubMed ID: 21123121
[TBL] [Abstract][Full Text] [Related]
19. LC-MS N-alkylamide profiling of an ethanolic Anacyclus pyrethrum root extract.
Boonen J; Sharma V; Dixit VK; Burvenich C; De Spiegeleer B
Planta Med; 2012 Nov; 78(16):1787-95. PubMed ID: 23047251
[TBL] [Abstract][Full Text] [Related]
20. Echinacea extracts modulate the pattern of chemokine and cytokine secretion in rhinovirus-infected and uninfected epithelial cells.
Sharma M; Arnason JT; Burt A; Hudson JB
Phytother Res; 2006 Feb; 20(2):147-52. PubMed ID: 16444669
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
